![Jeffrey Varsalone](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Jeffrey Varsalone
Presidente presso
MOTUS GI HOLDINGS, INC.
Profilo
Jeffrey Varsalone currently works at Motus GI Holdings, Inc., as President & Director from 2024 and Omega Therapeutics, Inc., as Director from 2025.
Mr. Varsalone also formerly worked at Rising Ground, Inc., as Director and EisnerAmper LLP, as Director.
Posizioni attive di Jeffrey Varsalone
| Società | Posizione | Inizio |
|---|---|---|
| MOTUS GI HOLDINGS, INC. | Presidente | 31/07/2024 |
| OMEA THER | Direttore/Membro del Consiglio | 24/01/2025 |
Precedenti posizioni note di Jeffrey Varsalone
| Società | Posizione | Fine |
|---|---|---|
EisnerAmper LLP
 EisnerAmper LLP Miscellaneous Commercial ServicesCommercial Services Provides accounting, auditing, tax, advisory and outsourcing services | Direttore/Membro del Consiglio | - |
Rising Ground, Inc.
 Rising Ground, Inc. Services to the Health IndustryHealth Services Provides individual and family social services | Direttore/Membro del Consiglio | - |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
15
Relazioni di 1° grado
4
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 4 |
|---|---|
Rising Ground, Inc.
Rising Ground, Inc. Services to the Health IndustryHealth Services Provides individual and family social services | Health Services |
EisnerAmper LLP
EisnerAmper LLP Miscellaneous Commercial ServicesCommercial Services Provides accounting, auditing, tax, advisory and outsourcing services | Commercial Services |
Motus GI Holdings, Inc.
 Motus GI Holdings, Inc. Medical SpecialtiesHealth Technology Develops and supplies pure-vu systems | Health Technology |
Omega Therapeutics, Inc.
 Omega Therapeutics, Inc. BiotechnologyHealth Technology Develops therapeutics for general and rare genetic diseases, immunology, inflammation, oncology and metabolic diseases | Health Technology |
